drugset / Trial / NCT01264354

An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

NCT01264354

Phase 4 Completed 60 enrolled Bukwang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an open study to evaluate the efficacy, safety of clevudine monotherapy or adefovir and clevudine combination in patients with chronic hepatitis B.

Timeline

Start
2010-03
Primary completion
2012-08
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir dipivoxil Small molecule 10 mg
Subject Clevudine Small molecule 20 mg
Subject Clevudine Small molecule 30 mg